Is 2024 going to be a bounce-back year for healthcare M&A? Or will sellers continue to cling onto high expected valuations? At the mid-point of the year, HBI 2024, June 10-12 is the perfect opportunity for healthcare investors and CEOs to meet, explore investment opportunities, discuss value creation strategies and perhaps even strike up a deal. 

Investment is sewn into the fabric of the event, and the agenda is teeming with insights and case studies from investors and CEOs.  Here are just a smattering of the sessions that will help you understand where, what and why to invest in 2024 and beyond: 

The 2024 M&A Landscape – A flagship keynote for HBI, Hedley Goldberg, Partner, Rothschild & Co deep dives into healthcare’s M&A markets, sharing rich data and analysis with predictions on how the second half of the year will play out. 

Getting deals done – New for 2024, Sharon Lamb and Stephan Rau, Partners at international Law firm, McDermott Will & Emery go beyond the headlines to analyse a selection of recent deals and share how in a challenging macro environment they got over the line. 

Investing in Healthcare – Join Arnaud Vincent, Managing Director – Healthcare, Eurazeo, Anastasya Molodykh McFarlane, Senior Principle, Cinven, Sebastien Veil, co-head of Healthcare, PAI Partners, James Sibley, Group Chief Financial Officer, M42 Healthcare and Martin Henrichs, Managing Director and Head of Healthcare EMEA, UBS 

Investing in healthcare property – A specific viewpoint on how property investing trends and opportunities in the cure, care and life science sectors. Join Steve Nitschke, Managing Director – Head of UK/Europe, Medical Properties Trust, Simon Betty, Head of Europe, NorthWest Healthcare Properties REIT and with market data from Sophie Cooper, Associate Director, CBRE

Investing in Emerging Markets Summit – In partnership with the IFC explore a huge range of perspectives on the realities of investing in these markets from: Alta Semper Capital, MidEuropa, Quadria Capital, IFHA, Ennismore Advisory, Africa Healthcare Network, Evercare Group and Siemens Healthineers.

The new healthcare powerhouse: Saudi Arabia – Hear directly about the opportunities to be a part of the most ambitious healthcare transformation programme the world has ever seen. Featuring Dr Khalid Aljihrish, Head of Sector Development, National Development Division, PIF, Dr Mahmoud Al Yamany, Head of Sector for Health, Wellbeing and Biotech, NEOM and Hamid Yunis, Partner, McDermott Will & Emery

Healthcare – the new era for infrastructure investors – A detailed case study of how and why infra and longer-term capital investment in healthcare over the forseeable future. Join Assia Belkahia, Partner, Antin Infrastructure Partners, Davide Tavinello and Rodolfo Guarino, Co-CEOs, Hippocrates Holdings. 

You will also get the chance to deep dives into the following verticals plus many more sessions on digital transformation, AI and leadership topics: 

• Vet services – featuring BC Partners, Univet and UBS

• Nuclear Medicine – featuring Alliance Medical, Curium RadioPharma, GE HealthCare and Rothschild & Co

• Elderly Care – featuring HC-One, Healthcare Activos, MaiVei Invest and L.E.K. Consulting 

• Occupational health – featuring Terveystalo, Latus Group, Medigold Health and Houlihan Lokey

• Aesthetics – featuring Bridgepoint, Bergman Clinics and L.E.K. Consulting 

• Ophthalmology – featuring Sanoptis, FYEO, Carl Zeiss Meditech and L.E.K. Consulting

• Imaging diagnostics – featuring evidia, Teleradiology Solutions and Incepto Medical AI

Get complete clarity on the investment opportunities in health and care and choose from more than 33 sessions to update your strategy and generate ideas. Packed with 600 plus CEOs and investment partners, HBI is the best place to meet the people taking the industry forward.